Pediatric Neurosurgery Unit, Catholic University Medical School, Largo Agostino Gemelli, 8, 00168, Rome, Italy.
Acta Neurochir (Wien). 2012 Aug;154(8):1517-22. doi: 10.1007/s00701-012-1381-6. Epub 2012 May 16.
Although endoscopic septostomy is widely adopted in the treatment of unilateral or specific types of hydrocephalus, there is no consensus on surgical indications, technical aspects and postoperative outcome. In particular, the choice of the ventricular access has been recently debated. We investigated the results of endoscopic septostomy performed through a standard precoronal ventricular access using a rigid endoscope.
Patients who underwent an endoscopic septostomy at our Institution from March 2001 to March 2011 were retrospectively identified. Clinico-radiological data and video recordings of the endoscopic procedures were reviewed.
Sixty-three patients (50 children and 13 adults) were collected. In adults, the obstruction of the cerebrospinal fluid (CSF) pathway was exclusively secondary to a tumor (neoplastic or pseudoneoplastic lesion). In the pediatric group hydrocephalus was most commonly due to a neoplasm (33 out of 50 patients), post-hemorrhagic and/or post-infectious hydrocephalus affecting 11 children and malformative hydrocephalus the remaining six children. We were able to perform the septostomy in all but two patients, presenting with a scarred multilayered septum secondary to post-hemorrhagic hydrocephalus. In 37 cases, one or more other endoscopic procedures were performed contemporarily. The mean follow-up was 24 months (min-max: 5-96 months). Overall, all but one patient benefited clinically and radiologically from the endoscopic septostomy. Two patients harboring a pineal/mesencephalic tumor experienced a late obstruction of the stoma secondary to neoplastic infiltration of the septum.
Endoscopic septostomy can be safely performed through a standard burr-hole. The effectiveness of this approach is testified by an early success rate of more than 95% and a long term success rate of 92%.
尽管内镜下房间隔造口术被广泛应用于单侧或特定类型脑积水的治疗,但在手术适应证、技术方面和术后结果方面尚未达成共识。特别是,脑室入路的选择最近受到了争议。我们调查了使用硬性内镜经标准冠状前脑室入路行内镜下房间隔造口术的结果。
回顾性分析 2001 年 3 月至 2011 年 3 月在我院行内镜下房间隔造口术的患者。对临床放射学数据和内镜手术录像进行了审查。
共收集到 63 例患者(50 例儿童和 13 例成人)。在成人中,脑脊液(CSF)通路梗阻仅继发于肿瘤(肿瘤或假性肿瘤病变)。在儿科组中,脑积水最常见的原因是肿瘤(50 例患者中有 33 例),出血后和/或感染后脑积水影响 11 例患儿,发育性脑积水影响其余 6 例患儿。除 2 例因出血后脑积水导致的瘢痕性多层隔外,我们能够对所有患者进行房间隔造口术。在 37 例患者中,同期进行了 1 次或多次其他内镜手术。平均随访时间为 24 个月(最短-最长:5-96 个月)。总体而言,除 1 例患者外,所有患者均从内镜下房间隔造口术中临床和放射学获益。2 例松果体/中脑肿瘤患者因肿瘤侵犯隔室导致造口术后期堵塞。
内镜下房间隔造口术可通过标准骨孔安全进行。该方法的有效性通过超过 95%的早期成功率和 92%的长期成功率得到证实。